D. E. Shaw & Co., Inc. Ani Pharmaceuticals Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 68,292 shares of ANIP stock, worth $5.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,292

Previous 229,701 70.27%

Holding current value

$5.77 Million

Previous $15.4 Million 71.02%

% of portfolio

0.0%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$57.79 - $72.95 $9.33 Million - $11.8 Million	-161,409 Reduced 70.27%	68,292 $4.46 Million
Q1 2025 May 15, 2025	BUY	$53.93 - $68.36 $1.8 Million - $2.28 Million	33,382 Added 17.0%	229,701 $15.4 Million
Q4 2024 Feb 14, 2025	BUY	$53.35 - $61.74 $4.68 Million - $5.41 Million	87,698 Added 80.74%	196,319 $10.9 Million
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $5.43 Million - $6.56 Million	99,861 Added 1139.97%	108,621 $6.48 Million
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $512,722 - $602,863	8,760 New	8,760 $557,000
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $338,337 - $490,289	-14,653 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $572,806 - $1 Million	-21,286 Reduced 59.23%	14,653 $412,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $607,439 - $1.05 Million	18,424 Added 105.19%	35,939 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $195,925 - $266,290	-7,399 Reduced 29.7%	17,515 $575,000
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $440,687 - $533,915	-13,832 Reduced 35.7%	24,914 $873,000
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $348,922 - $444,016	12,286 Added 46.43%	38,746 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $626,837 - $832,696	26,460 New	26,460 $768,000
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $494,533 - $827,802	-16,523 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $621,628 - $1.38 Million	-20,482 Reduced 55.35%	16,523 $673,000
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $153,371 - $220,011	2,756 Added 8.05%	37,005 $2.28 Million
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $1.22 Million - $1.61 Million	18,892 Added 123.02%	34,249 $2.5 Million
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $559,441 - $678,561	8,255 Added 116.23%	15,357 $1.26 Million
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $59,945 - $92,266	1,308 Added 22.58%	7,102 $501,000
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $28,819 - $39,508	700 Added 13.74%	5,794 $261,000
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $269,727 - $363,405	5,094 New	5,094 $288,000

Others Institutions Holding ANIP

# of Institutions

261

Shares Held

19.3M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.47B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account